Stockreport

The FDA Paused This Biotech's Gene Therapy Study — And Shares Tumbled [Investor's Business Daily]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF Related news 11/05/2019 Mylan stock slipped Tuesday after the pharmaceutical company reported adjusted earnings of $1.17 per share, beating estimates. But sales of... [Read more]